Sabcomeline HCl is a selective M1 muscarinic acetylcholine receptor agonist used in Alzheimer's disease research. It is employed in both in vitro and in vivo studies to investigate cholinergic signaling, cognitive function, and potential therapeutic strategies for neurodegenerative disorders.